- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/02 - Nasal agents, e.g. decongestants
Patent holdings for IPC class A61P 11/02
Total number of patents in this class: 764
10-year publication summary
|
46
|
36
|
41
|
52
|
55
|
67
|
58
|
50
|
47
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Taisho Pharmaceutical Co., Ltd. | 860 |
18 |
| Dainippon Sumitomo Pharma Co., Ltd. | 216 |
14 |
| Daiichi Sankyo Company, Limited | 1864 |
13 |
| The Procter & Gamble Company | 22165 |
11 |
| Mitsubishi Tanabe Pharma Corporation | 575 |
11 |
| Schering Corporation | 508 |
11 |
| Shionogi & Co., Ltd. | 889 |
11 |
| KYORIN Pharmaceutical Co., Ltd. | 175 |
10 |
| Ono Pharmaceutical Co., Ltd. | 436 |
10 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 283 |
9 |
| Santen Pharmaceutical Co., Ltd. | 626 |
9 |
| Kyowa Hakko Kirin Co., Ltd. | 284 |
8 |
| AstraZeneca AB | 2961 |
7 |
| Igisu Co., Ltd | 22 |
7 |
| Mochida Pharmaceutical Co., Ltd. | 344 |
7 |
| Takeda Pharmaceutical Company Limited | 2945 |
6 |
| Astellas Pharma Inc. | 1122 |
6 |
| Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH | 132 |
6 |
| Cyrano Therapeutics, Inc. | 35 |
6 |
| Merck Sharp & Dohme Corp. | 2219 |
5 |
| Other owners | 579 |